The DOI matches its OpenAlex record; 26 of the 26 references it cites were found in a registry or an index.
Thyrotropin-Secreting Pituitary Tumors: Diagnostic Criteria, Thyroid Hormone Sensitivity, and Treatment Outcome in 25 Patients Followed at the National Institutes of Health
Open accessAbstract
We report a large series of 25 patients with TSH-secreting tumors (23 macroadenomas) followed at the NIH. Hyperthyroid symptoms were severe in 14 patients, mild in 8, and absent in 3. Patients were divided into 2 groups according to whether their thyroid had been treated (n = 11) or not (n = 14). In untreated patients, the classical diagnostic criteria (unresponsive TRH test, high alpha-subunit, and high alpha-subunit/TSH ratio) were present, respectively, in 10, 8, and 12 cases (sensitivity, 71%, 75%, and 83%; specificity, 96%, 90%, and 65%). In treated patients, the respective sensitivities of the TRH test, alpha-subunit, and alpha-subunit/TSH ratio were 64%, 90%, and 90%, and their specificities were 100%, 82%, and 73%. Studies of thyroid hormone action revealed no evidence of acquired resistance to thyroid hormone in TSH-secreting tumors. Apparent cure was achieved in 35% of cases by surgery alone and in 22% more by combined therapies. Three deaths occurred, including 1 from metastatic thyrotroph carcinoma. Six patients had residual tumor, with symptoms of hyperthyroidism controlled with octreotide in 5. The size and invasiveness of the tumor, duration of symptoms, and intensity of hyperthyroidism were the main prognostic factors. Thus, early diagnosis and treatment are the keys to a good outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Syndromes of Resistance to Thyroid Hormone*
REFETOFF, S., WEISS, R. E., & USALA, S. J. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-3-348 · Cited by 873
Hall, W. A., Luciano, M. G., Doppman, J. L., Patronas, N. J., & Oldfield, E. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-10-199405150-00001 · Cited by 627
Self-citationThyrotropin-Secreting Pituitary Tumors*
BECK-PECCOZ, P., BRUCKER-DAVIS, F., PERSANI, L., SMALLRIDGE, R. C., & WEINTRAUB, B. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-6-610 · Cited by 491
Self-citationBrucker-Davis, F., Skarulis, M. C., Grace, M. B., Benichou, J., Hauser, P., Wiggs, E., & Weintraub, B. D. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-8-199510150-00002 · Cited by 275
Self-citationChanson, P., Weintraub, B. D., & Harris, A. G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-3-199308010-00010 · Cited by 212
Self-citationGreenman, Y. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.3.724 · Cited by 190
Inappropriate secretion of thyroid stimulating hormone.
Kourides, I. A. (1994) · PubMed · Cited by 183
KOURIDES, I. A., RIDGWAY, E. C., WEINTRAUB, B. D., BIGOS, S. T., GERSHENGORN, M. C., & MALOOF, F. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-3-534 · Cited by 176
Self-citationResponse of Thyrotropin-Secreting Pituitary Adenomas to a Long-Acting Somatostatin Analogue
Comi, R. J., Gesundheit, N., Murray, L., Görden, P., & Weintraub, B. D. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707023170103 · Cited by 151
Self-citationLosa, M., Giovanelli, M. A., Persani, L., Mortini, P., Faglia, G., & Beck‐Peccoz, P. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768879 · Cited by 145
Thyrotropin-Secreting Pituitary Adenomas: Clinical and Biochemical Heterogeneity
Gesundheit, N., Petrick, P. A., Nissim, M., Dahlberg, P. A., Doppman, J. L., Emerson, C. H., Braverman, L. E., Oldfield, E. H., & Bruce, D. W. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-10-827 · Cited by 142
Self-citationVariable biological activity of thyroid-stimulating hormone
Beck-Peccoz, P., & Persani, L. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1310331 · Cited by 116 · cited 2×
“5 (8) Length of symptoms (yr) 9 6 2 6 6 2 12 6 3 Range 0–26 0–15 2–26 Thyrotoxicosis (n) (25) (14) (11) Absent % 12 21 0 Mild % 32 36 27 Severe % 56 43 73 (123)I 24-h uptake (%) 36 6 6 39 6 8 29 6 13 Goiter %(n) 80 (25) 79 (14) 82 (11) Thyroid nodule %(n) 64 (22) 77 (13) 44 (9) Headaches %(n) 39 (23) 36 (14) 44 (9) Vi…”
BackgroundThyrotropin-producing pituitary adenomas
Mindermann, T., & Wilson, C. B. (1993) · Journal of neurosurgery · doi:10.3171/jns.1993.79.4.0521 · Cited by 111
Ştefăneanu, L., Kovács, K., Horváth, É., Lloyd, R. V., Buchfelder, M., Fahlbusch, R., & Smyth, H. S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.1.8288720 · Cited by 109
Bertherat, J. Y., Brue, T. C., Enjalbert, A., Gunz, G., Rasolonjanahary, R., Warnet, A., Jaquet, P., & Epelbaum, J. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.2.1353505 · Cited by 103
Thyrotropin-Secreting Pituitary Adenomas: Report of Seven Cases
Beckers, A. M., Abs, R., Mahler, C., et al. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-477 · Cited by 99
Inappropriate Secretion of Thyrotropin by the Pituitary
Faglia, G., Beck‐Peccoz, P., Piscitelli, G., & MEDRI, G. (2008) · Hormone Research · doi:10.1159/000180687 · Cited by 97
Dopamine, the dopamine D2 receptor and pituitary tumours
Wood, D., Johnston, J., & Johnston, D. G. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb00928.x · Cited by 96
Beck‐Peccoz, P., Roncoroni, R., Mariotti, S., et al. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-1-19 · Cited by 94
Isolated hyponatremia after transsphenoidal pituitary surgery
Olson, B. R., Rubino, D., Gumowski, J., & Oldfield, E. H. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.1.7829644 · Cited by 87
Self-citationGlycoprotein hormone α-subunit in pituitary adenomas
Beck‐Peccoz, P., Persani, L., & Faglia, G. (1992) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(92)90041-x · Cited by 78
Ezzat, S., Horváth, É., Kovács, K., et al. (1995) · Endocrine Pathology · doi:10.1007/bf02739875 · Cited by 68
Thyrotropin-producing microadenoma associated with pituitary resistance to thyroid hormone
Watanabe, K., Kameya, T., Yamauchi, A., Yamamoto, N., Kuwayama, A., Takei, I., Maruyama, H., & Saruta, T. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.4.8473377 · Cited by 52
Glycoprotein-secreting pituitary adenomas
Samuels, M. H., & Ridgway, E. C. (1995) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80370-x · Cited by 31
Mechanisms of action of somatostatin on human TSH-secreting adenoma cells
Takano, K., Ajima, M., Teramoto, A., Hata, K., & Yamashita, N. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.4.e558 · Cited by 25
Thyroid-stimulating hormone pituitary adenomas and hyperthyroidism
Grisoli, F., Leclercq, T. A., Winteler, J.-P., et al. (1986) · Surgical Neurology · doi:10.1016/0090-3019(86)90211-9 · Cited by 18
Cited by
Beck-Peccoz, P., Lania, A., Beckers, A., Chatterjee, K., & Wemeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000351007 · Cited by 283
The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients
Socin, H., Chanson, P., Delemer, B., Tabarin, A., Rohmer, V, Mockel, J., Stevenaert, A., & Beckers, A. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480433 · Cited by 274
Somatostatin Analogs in Clinical Practice: A Review
Gomes-Porras, M., Cárdenas-Salas, J., & Álvarez-Escolá, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051682 · Cited by 264
Hypothalamic Hormones and Cancer
Schally, A. V., Comaru-Schally, A. M., Nagy, A., Kovacs, M., Szepeshazi, K., Plonowski, A., Varga, J. L., & Halmos, G. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0217 · Cited by 254
National Incidence and Prevalence of TSH-Secreting Pituitary Adenomas in Sweden
Önnestam, L., Berinder, K., Burman, P., Dahlqvist, P., Engström, B. E., Wahlberg, J., & Nyström, H. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3362 · Cited by 148
Metadata
- Authors
- Brücker-Davis, F., Oldfield, E. H., Skarulis, M. C., Doppman, J. L., & Weintraub, B. D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- Oxford University Press
- Published
- 1999-02-01
- Volume
- 84
- Issue
- 2
- Pages
- 476-486
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2054825056
- Cited by
- 311
- References
- 26
- FWCI
- 8.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.